The popularity of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has increased in recent years (Rodriguez et al., 2023)
N Engl J Med 380(24):22952306 Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
This compound not only supports glutathione levels but also provides additional cardiovascular and immune system benefits
What to Do Next If you are ready to start supporting your cellular health, here is a simple path forward: Assess your goals: Are you focused on liver health, respiratory support, or general anti-ageing